Tetra Bio-Pharma Inc. A Leader In Cannabinoid-Derived Drug Discovery And Development Announced Today That It Has Executed A Non-Binding Term Sheet With Avicanna Inc. To Assess Entering Into A Strategic Partnership Comprising Of Three Strategic Pillars, Including: The Registration And Commercialization Of Tetra'S Various Prescription Products (Reduvo
